Agenda Unveiled | 2026 WAIC Qiming Venture Partners Entrepreneurship and Investment Forum: The Evolutionary Journey from Computing Power Origin to Application Landing

Qiming Venture Partners Entrepreneurship & Investment Forum: The Evolution from Compute Origins to Application Deployment

Sunday, July 19, 2:00 PM at the World Artificial Intelligence Conference

Silver Hall B, 1st Floor, Shanghai World Expo Center

This is a sub-forum exploring AI's journey from underlying compute infrastructure to industrial deployment — through the lens of innovation and entrepreneurship.

We will be joined by leading scholars and pioneering founders in this space to bring you:

3 keynote speeches

1 in-depth dialogue

1 roundtable discussion

3 major announcements

How will the evolution of compute infrastructure support the full-stack advancement of the AI industry?

How does AI evolve from "technical ideal" to "industrial engine"? How can real-world scenarios generate efficient, sustainable AI commercial value? What differences exist in AI governance approaches across countries? How can we build a secure and sustainable AI governance framework?

Forum agenda below

We look forward to seeing you there for our speakers' insights!

Public Registration GuideRegistration closes at 23:59 on July 14, 2026Limited spots available — first come, first served

P A S T H I G H L I G H T S

Qiming Weekly | 10 News Items from Qiming Venture Partners Portfolio Companies Vol. 22, June 30, 2026 Qiming Perspectives | Duane Kuang, Qiming Venture Partners: Embrace the Cycle, Ride Through the Cycle — AI Will Be an Unusually Long Technology Cycle Qiming Honors | 5 Qiming Venture Partners Investors Named to 2025 Forbes China Midas List

Qiming Venture Partners was founded in 2006. The firm currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, Qiming Venture Partners has focused on investing in outstanding early- and growth-stage companies in Technology and Healthcare.

To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies, of which more than 210 have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through M&A and other means. Over 80 portfolio companies have become recognized unicorns or super-unicorns.

Many companies in Qiming Venture Partners' portfolio have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), Hesai Technology (NASDAQ:HSAI, 02525.HK), UBTECH (09880.HK), WeRide (NASDAQ:WRD, 00800.HK), HyperStrong (688411.SH), Insta360 (688775.SH), Unisound (09678.HK), Biren Technology (06082.HK), Zhipu AI (02513.HK), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Sinocelltech (688520.SH), Insilico Medicine (03696.HK), Argo Biopharma, Yuanxin Technology, MediLink Therapeutics, LaNova Medicines, StepFun, and others.